Overview

Mifepristone Versus Laminaria Insertion for Cervical Preparation Prior to Surgical Abortion at 14-16 Weeks

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
Women who are requesting pregnancy termination at 14-16 weeks, who would normally have osmotic dilator insertion the day before their procedure, would be asked if they wanted to participate. Participants would be randomized to two groups: first, dilator insertion as usual, or second, mifepristone taken the day before the procedure.
Phase:
N/A
Details
Lead Sponsor:
Boston University
Collaborator:
Society of Family Planning
Treatments:
Mifepristone